R-L-ribo-Configured Locked Nucleic Acid
A R T I C L E S
the mixture was filtered through a layer of Celite 545. The layer of
Celite 545 was washed with CH2Cl2 (2 × 50 mL) and the combined
filtrates were washed successively with a saturated aqueous solution
of NaHCO3 (3 × 150 mL) and H2O (2 × 150 mL), dried (Na2SO4),
and evaporated to dryness under reduced pressure. The residue was
purified by silica gel column chromatography with EtOAc/petroleum
ether (40-60% EtOAc by volume) as eluent to give nucleoside 11 as
a white solid material (1.40 g, 52%). Rf 0.40 (MeOH/CH2Cl2, 2/23 v/v);
FAB-MS m/z 742 [M + H]+; 1H NMR (CDCl3) δ 9.60 (br s, 1H, 6-H),
8.73 (s, 1H, 8-H), 8.51 (s, 1H, 2-H), 8.02-7.98 (m, 4H), 7.89-7.86
(m, 2H), 7.58-7.16 (m, 14H), 6.58 (d, 1H, J ) 2.6 Hz, 1′-H), 5.88 (t,
1H, J ) 2.2 Hz, 2′-H), 4.93 (d, 1H, J ) 12.0 Hz, Bn), 4.79 (d, 1H, J
) 12.0 Hz, Bn), 4.70-4.61 (m, 4H), 4.34 (d, 1H, J ) 1.8 Hz, 3′-H),
2.17 (s, 3H, Ac); 13C NMR (CDCl3) δ 169.3, 165.5, 165.3, 152.3, 151.3,
149.4, 135.5, 133.3, 133.1, 132.9, 132.3, 129.3, 129.3, 129.1, 128.7,
128.3, 128.2, 128.1, 128.1, 128.0, 128.0, 127.6, 122.8 (Bn, Bz, Ac,
C-4, C-5, C-6, C-8), 141.1 (C-2), 87.2, 87.0 (C-1′, C-4′), 80.8 (C-3′),
80.1 (C-2′), 72.2 (Bn), 62.7, 62.3 (C-5′, C-5′′), 20.5 (Ac).
residue was purified by silica gel column chromatography with MeOH/
CH2Cl2 (4-6% MeOH by volume) as eluent, yielding nucleoside 15
(656 mg, 91%) as a white foam, which was used in the next step without
further purification. Rf 0.47 (MeOH/CH2Cl2, 1/9); FAB-MS m/z 492
1
[M + H]+; H NMR [(CD3)2SO] δ 11.18 (br s, 1H, 6-NH), 8.75 (s,
1H, 2-H), 8.66 (s, 1H, 8-H), 8.07-7.95 (m, 2H), 7.67-7.29 (m, 8H),
6.48 (d, 1H, J ) 4.8 Hz, 1′-H), 5.92 (br s, 1H, 2′-OH), 5.35 (br s, 1H),
5.09 (br s, 1H), 4.81 (d, 1H, J ) 11.6 Hz), 4.67 (m, 1H, 2′-H), 4.62 (d,
1H, J ) 11.6 Hz) 4.40 (d, 1H, J ) 5.0 Hz, 3′-H), 3.70 (d, 1H, J )
11.6 Hz), 3.63 (d, 1H, J ) 11.5 Hz), 3.54 (s, 2H); 13C NMR [(CD3)2-
SO] δ 164.7, 151.5, 150.1, 138.4, 133.5, 132.8, 132.7, 129.3, 128.6,
128.5, 128.3, 127.6, 127.5, 125.1 (Bn, Bz, C-4, C-5, C-6), 152.3 (C-
2), 144.4 (C-8), 110.4, 87.8 (C-4′), 83.7 (C-1′), 79.4 (C-3′), 72.5 (Bn),
69.9 (C-2′), 63.3, 61.1 (C-5′, C-5′′).
9-[3-O-Benzyl-5-O-(methanesulfonyl)-4-C-[[(methanesulfonyl)-
oxy]methyl]-r-L-erythro-pentofuranosyl]-6-N-benzoyladenine (16).
Nucleoside 15 (1.75 g, 3.57 mmol) was coevaporated with anhydrous
pyridine (100 mL) and dissolved in anhydrous pyridine (100 mL). The
mixture was cooled to 0 °C and methanesulfonyl chloride (0.61 mL,
7.9 mmol) was added dropwise. After the mixture was stirred for 2 h,
H2O (10 mL) was added and the mixture was evaporated to dryness
under reduced pressure. The residue was dissolved in CH2Cl2 (75 mL)
and washed with a saturated aqueous solution of NaHCO3 (3 × 75
mL) and dried (Na2SO4). The organic phase was evaporated to dryness
under reduced pressure and the residue was purified by silica gel column
chromatography with CH2Cl2/MeOH (2-4% MeOH by volume) as
eluent, affording nucleoside 16 (1.83 g, 79%) as a white solid material.
9-[2-O-Acetyl-5-O-benzoyl-4-C-[(benzoyloxy)methyl]-3-O-benzyl-
r-L-erythro-pentofuranosyl]-6-N-benzoyladenine (14). To a solution
of nucleoside 11 (3.63 g, 4.90 mmol) in MeOH (75 mL) was added a
saturated solution of NH3 in MeOH (75 mL). The solution was stirred
at 0 °C for 2 h and evaporated to dryness under reduced pressure. The
residue was coevaporated with anhydrous toluene (2 × 40 mL) and
dissolved in a mixture of anhydrous CH2Cl2 (100 mL) and anhydrous
pyridine (20 mL). After the mixture was cooled to -30 °C, trifluo-
romethanesulfonic anhydride (1.7 mL, 10.3 mmol) was added dropwise.
The reaction mixture was allowed to warm to room temperature, and
after 1.5 h additional trifluoromethanesulfonic anhydride (0.5 mL, 3.03
mmol) was added. After being stirred for an additional 30 min, the
mixture was diluted with CH2Cl2 (130 mL), washed with a saturated
aqueous solution of NaHCO3 (3 × 200 mL) and dried (Na2SO4). After
evaporation of the solvents, the residue was coevaporated with
anhydrous toluene (2 × 75 mL) and dissolved in anhydrous toluene
(150 mL). KOAc (2.45 g, 25.0 mmol) and 18-crown-6 (2.56 g, 9.70
mmol) were added, and the mixture was stirred for 30 min at room
temperature and then heated to 80 °C for 30 min. The mixture was
cooled to room temperature and evaporated to dryness under reduced
pressure. The residue was purified by silica gel column chromatography
with MeOH/CH2Cl2 (0-2% MeOH by volume) as eluent, affording
nucleoside 14 (3.05 g, 84%) as a white solid material. Rf 0.44 (MeOH/
1
Rf 0.63 (MeOH/CH2Cl2, 1/9 v/v); FAB-MS m/z 648 [M + H]+; H
NMR (CDCl3) δ 9.10 (s, 1H, 6-NH), 8.52 (s, 1H, 8-H), 8.48 (s, 1H,
2-H), 7.96-7.95 (m, 2H), 7,62-7.31 (m, 8H), 6.46 (d, 1H, J ) 3.7
Hz, 1′-H), 5.42 (br s, 1H, 2′-OH), 5.04 (d, 1H, J ) 11.7 Hz, 3′-H),
4.79 (d, 1H, J ) 11.7 Hz, Bn), 4.68 (br s, 1H, 2′-H), 4.58 (d, 1H, J )
11.7 Hz, Bn), 4.45-4.26 (m, 4H, 5′-H, 5′′-H), 3.03 (s, 3H, Ms), 3.01
(s, 3H, Ms); 13C NMR (CDCl3) δ 174.3, 164.8, 151.6, 148.5, 136.3,
133.4, 132.9, 128.9, 128.8, 128.7, 128.5, 127.9, 121.8 (Bn, Bz, C-4,
C-5, C-6), 152.1 (C-2), 143.5 (C-8), 84.8 (C-1′), 82.4 (C-4′), 78.8, 68.3
(C-5′, C-5′′), 73.6 (Bn), 70.3 (C-2′), 69.0 (C-3′), 37.7 (Ms), 37.6 (Ms).
(1S,3R,4S,7R)-1-(Acetoxymethyl)-3-(6-N-benzoyladenin-9-yl)-7-
benzyloxy-2,5-dioxabicyclo[2.2.1]heptane (18). Nucleoside 16 (1.31
g, 2.02 mmol) was coevaporated with anhydrous toluene (50 mL) and
dissolved in anhydrous THF (50 mL). The mixture was cooled to 0 °C
and NaH [60% suspension in mineral oil (by weight), 175 mg, 4.38
mmol] was added. After being stirred at 0 °C for 6.5 h, the reaction
mixture was evaporated to dryness under reduced pressure and the
residue was dissolved in CH2Cl2 (100 mL). Washing was performed
with a saturated aqueous solution of NaHCO3 (3 × 100 mL) and the
organic phase was dried (Na2SO4) and evaporated to dryness under
reduced pressure. The residue was dissolved in 1,4-dioxane (50 mL),
and KOAc (1.02 g, 10.4 mmol) and 18-crown-6 (1.08 g, 4.09 mmol)
were added. The mixture was heated under reflux for 19 h and
subsequently evaporated to dryness under reduced pressure. The residue
was purified by silica gel column chromatography with CH2Cl2/MeOH
(0.5% MeOH by volume) as eluent, yielding nucleoside 18 (911 mg,
87%) as a white solid material, which was used in the next step without
further purification. Rf 0.60 (MeOH/CH2Cl2, 1/9 v/v); FAB-MS m/z
1
CH2Cl2, 1/19 v/v); FAB-MS m/z 742 [M + H]+; H NMR (CDCl3) δ
9.00 (br s, 1H, 6-NH), 8.76 (s, 1H, 8-H), 8.59 (s, 1H, 2-H), 8.05-7.98
(m, 6H), 7.64-7.41 (m, 10H), 7.28-7.23 (m, 4H), 6.77 (d, 1H, J )
4.6 Hz, 1′-H), 5.86 (m, 1H, H-2′), 5.23 (d, 1H, J ) 12.3 Hz), 4.74-
4.66 (m, 3H), 4.56-4.50 (m, 3H), 2.04 (s, 3H, Ac); 13C NMR (CDCl3)
δ 168.8, 165.8, 142.7, 136.0, 133.5, 133.3, 132.7, 129.6, 129.6, 128.8,
128.6, 128.5, 128.4, 128.4, 128.1, 127.8 (Bn, Bz, Ac, C-2, C-4, C-5,
C-6, C-8), 83.8 (C-4′), 82.2 (C-1′), 78.4 (C-3′), 74.3 (Bn), 70.8 (C-2′),
64.7, 63.4 (C-5′, C-5′′), 20.5 (Ac).
9-[3-O-Benzyl-4-C-(hydroxymethyl)-r-L-erythro-pentofuranosyl]-
6-N-benzoyladenine (15). Nucleoside 14 (1.09 g, 1.47 mmol) was
dissolved in a saturated solution of NH3 in MeOH (40 mL). After the
mixture was stirred for 30 min at room temperature, an aqueous solution
of NH3 (10 mL, 32% by weight) was added. After 22 h, the mixture
was evaporated to dryness under reduced pressure and the residue, after
coevaporation with anhydrous pyridine (3 × 20 mL), was dissolved in
anhydrous pyridine (20 mL). Chlorotrimethylsilane (2.8 mL, 22 mmol)
was added and stirring was continued for 2.5 h at room temperature.
The reaction mixture was cooled to 0 °C, BzCl (0.9 mL, 7.8 mmol)
was added, and stirring was continued for 16.5 h at room temperature.
After the mixture was cooled to 0 °C, water (40 mL) was added and
the mixture was evaporated to dryness under reduced pressure. The
residue was dissolved in H2O/MeOH/saturated methanolic ammonia
(65 mL, 3/4/6 v/v/v), and the mixture was stirred for 6.5 h at room
temperature and evaporated to dryness under reduced pressure. The
1
516 [M + H]+; H NMR (CDCl3) δ 9.37 (br s, 1H, 6-NH), 8.72 (s,
1H, 8-H), 8.51 (s, 1H, 2-H), 8.04-8.02 (m, 2H), 7.60-7.33 (m, 8H),
6.46 (s, 1H, 1′-H), 4.76 (d, 1H, J ) 11.9 Hz, Bn), 4.66 (d, 1H, J )
11.7 Hz, Bn), 4.65 (s, 1H, 2′-H), 4.50 (d, 1H, J ) 12.6 Hz, 5′′-H),
4.38 (d, 1H, J ) 12.6 Hz, 5′′-H), 4.33 (s, 1H, 3′-H), 4.30 (d, 1H, J )
8.4 Hz, 5′-H), 4.11 (d, 1H, J ) 8.2 Hz, 5′-H), 2.06 (s, 3H, Ac); 13C
NMR (CDCl3) δ 170.1 (Ac), 164.3, 152.4, 151.9, 149.5, 141.2, 136.4,
133.5, 132.5, 128.6, 128.5, 128.2, 127.8, 127.6, 122.8, (C-2, C-4, C-5,
C-6, C-8, Bz, Bn), 87.0 (C-4′), 84.5 (C-1′), 79.7 (C-3′), 77.1 (C-2′),
73.5 (C-5′), 72.3 (Bn), 59.7 (C-5′′), 20.5 (Ac).
9
J. AM. CHEM. SOC. VOL. 124, NO. 10, 2002 2173